These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12032574)

  • 1. Promises kept and broken: new pharmaceuticals.
    Malik P
    Can J Cardiol; 2002 May; 18(5):493-4. PubMed ID: 12032574
    [No Abstract]   [Full Text] [Related]  

  • 2. What future does the pharmaceutical industry have in the cardiovascular world?
    Braunwald E
    Eur Heart J; 2013 Apr; 34(13):943-4. PubMed ID: 23546415
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular combinations.
    Glass G
    Nat Rev Drug Discov; 2004 Sep; 3(9):731-2. PubMed ID: 15368657
    [No Abstract]   [Full Text] [Related]  

  • 4. Omapatrilat for the management of heart failure and hypertension.
    Husereau DR
    Issues Emerg Health Technol; 2001 Jun; (17):1-4. PubMed ID: 11776285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Industry reneges on postmarketing trial commitments.
    Bouchie A
    Nat Biotechnol; 2003 Jul; 21(7):718. PubMed ID: 12833074
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug regulation 2056.
    Bezold C; Peck J
    Food Drug Law J; 2005; 60(2):127-36. PubMed ID: 16097091
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular pipeline decline quantified.
    Mullard A
    Nat Rev Drug Discov; 2016 Sep; 15(10):669. PubMed ID: 27681785
    [No Abstract]   [Full Text] [Related]  

  • 8. Omapatrilat: a unique new agent for the treatment of cardiovascular disease.
    Nawarskas JJ; Anderson JR
    Heart Dis; 2000; 2(3):266-74. PubMed ID: 11728268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure].
    Latini R
    Ital Heart J Suppl; 2001 Jan; 2(1):83-4. PubMed ID: 11216088
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomised trial of three counselling strategies for lifestyle changes in patients with hypercholesterolemia treated with ezetimibe on top of statin therapy (TWICE).
    Steg PG; Verdier JC; Carré F; Darne B; Ducardonnet A; Jullien G; Farnier M; Giral P; Haïat R;
    Arch Cardiovasc Dis; 2008; 101(11-12):723-35. PubMed ID: 19059567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canaries, coal mines and the drug supply.
    Leiden JM
    Nat Biotechnol; 2008 Jun; 26(6):624-6. PubMed ID: 18536681
    [No Abstract]   [Full Text] [Related]  

  • 12. What you don't know will hurt you.
    Nat Biotechnol; 2008 Jun; 26(6):589. PubMed ID: 18536658
    [No Abstract]   [Full Text] [Related]  

  • 13. The FDA and safety--beyond the heparin crisis.
    Laurencin CT; Nair L
    Nat Biotechnol; 2008 Jun; 26(6):621-3. PubMed ID: 18536680
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stable coronary heart disease--lessons from the COURAGE Study. With intensive drug therapy on the success track].
    MMW Fortschr Med; 2008 Jun; 150(23):38-9. PubMed ID: 18575368
    [No Abstract]   [Full Text] [Related]  

  • 15. The Zetia challenge: an update.
    Johns Hopkins Med Lett Health After 50; 2009 Apr; 21(2):6. PubMed ID: 19489149
    [No Abstract]   [Full Text] [Related]  

  • 16. PHARMAC and cardiovascular health in New Zealand.
    Moodie P
    N Z Med J; 2008 Mar; 121(1270):102-5. PubMed ID: 18364762
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of novel anti-hyperlipidemic drugs: a tough business gets tougher.
    Krause BR
    Curr Opin Investig Drugs; 2008 Sep; 9(9):945-9. PubMed ID: 18729000
    [No Abstract]   [Full Text] [Related]  

  • 18. Discontinued drugs in 2008: cardiovascular drugs.
    Zhang XS; Xiang BR
    Expert Opin Investig Drugs; 2009 Jul; 18(7):875-85. PubMed ID: 19548849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk factor reduction. Cholesterol absorption inhibitors: a new action principle].
    Schunack W
    Pharm Unserer Zeit; 2003; 32(6):498-502. PubMed ID: 14639831
    [No Abstract]   [Full Text] [Related]  

  • 20. [Omapatrilat--new drug for patients with hypertension and heart failure].
    Dzielska-Olczak M
    Pol Merkur Lekarski; 2005 Oct; 19(112):556-8. PubMed ID: 16379325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.